in this issue
EnviroTech :: Biotech
Symrise Enters Health Sector
10:16 AM MDT | April 28, 2008 | Kate Phillips
Symrise says it has entered the health market through a strategic partnership with Cambridge Theranostics (Cambridge, U.K.), a bio-tech firm specializing in the diagnostics and prophylaxis of cardiovascular diseases. Symrise says it will contribute up to €8 million ($12.7 million) in “milestone-related payments” toward the development and clinical evaluation of new health and medical food products, under terms of the deal. Both companies will share profits on products resulting from the collaboration, Symrise says. Cambridge Theranostics will use...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee